Heads roll as JNJ seeks to strengthen ailing medtech biz
This article was originally published in Clinica
Executive Summary
Johnson & Johnson may have led the medtech industry for many years, but its increasingly weakening hold of the top position was confirmed today, following news that the healthcare giant was cutting around 3,000 jobs in its orthopedics, surgery and cardiovascular businesses to reduce costs and hopefully turn the division around.